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Abstract
The Naqrdicarboxylate cotransporter, NaDC-1, and the Naqrsulfate cotransporter, NaSi-1, share 43% sequence
identity, but they exhibit no overlap in substrate specificity. A functional chimera, SiDC-4, was prepared from NaDC-1 and
NaSi-1 by homologous recombination and expressed in Xenopus oocytes. SiDC-4 contains putative transmembrane
 . domains 1–4 of NaSi-1 amino acids 1–139 and putative transmembrane domains 5–11 of NaDC-1 amino acids
.141–593 . SiDC-4 retains the substrate specificity of NaDC-1, which suggests that the substrate recognition domain is
found in the carboxy-terminal portion of the protein, past amino acid 141. However, residues that affect substrate affinity
and inhibition by furosemide and flufenamate are found in the amino terminal third of the protein. The cation binding
properties of SiDC-4, including a stimulation of transport by lithium, differed from both parental transporters, suggesting
that cation binding is determined by interactions between the amino- and carboxy-terminal portions of the protein. We
conclude that the substrate recognition site of NaDC-1 and NaSi-1 is found in the carboxy-terminal portion of the protein,
past amino acid 141, but residues in the amino terminus can affect substrate affinity, inhibitor sensitivity, and cation
selectivity. q 1998 Elsevier Science B.V.
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1. Introduction
The transport of dicarboxylates and sulfate in the
renal proximal tubule is mediated by distinct
w x qsodium-coupled transport proteins 1 . The Na rdi-
carboxylate cotransporter, NaDC-1, absorbs Krebs
cycle intermediates such as succinate and citrate from
) Corresponding author. Fax: q1 520-626-2383; E-mail:
Pajor@biosci.arizona.edu
w x qthe tubular filtrate 2 . The renal Na rsulfate co-
w xtransporter, NaSi-1, carries inorganic sulfate 3 .
NaDC-1 and NaSi-1 are members of the same gene
family and exhibit 43% sequence identity. The hy-
dropathy profiles of NaDC-1 and NaSi-1 resemble
one another, and their secondary structures are also
likely to be similar. The current model of NaDC-1
secondary structure contains 11 transmembrane do-
mains and a single N-glycosylation site located at the
w xC-terminus 4 . Functionally, there is no overlap in
substrate specificity between NaDC-1 and NaSi-1,
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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but both transporters couple 3 sodium ions to the
w xtransport of a divalent anion substrate 2,5 .
The structural domains responsible for sodium
binding and substrate discrimination in NaDC-1 and
NaSi-1 have not yet been determined. Chimeras be-
tween structurally-related transporters with distinct
functions can help to identify domains that determine
these differences in function. In the present study, we
report the formation of a functionally active chimera,
SiDC-4, which retains the substrate binding charac-
teristics of the parental, NaDC-1. The results suggest
that the substrate recognition site in the members of
this gene family is found in the carboxy-terminal
portion of the protein, distal to amino acid 141.
2. Methods
2.1. Formation of chimeras by homologous recom-
bination
w xThe technique of homologous recombination 6,7
was used to prepare chimeras between the Naqrdi-
carboxylate, NaDC-1, and Naqrsulfate, NaSi-1, co-
transporters. Both cDNAs were originally cloned in
the Sal I and NotI sites of the vector pSPORT. A
tandem construct, SiDC, was made, which consisted
of NaSi-1 cDNA followed by NaDC-1 cDNA in
pSPORT separated by two unique restriction sites,
MunI and Sal I. To prepare the SiDC construct, the
Sal I site in NaSi-1 plasmid was removed by diges-
tion with Sal I, followed by blunting with Klenow,
and subsequent relegation. The NaDC-1 cDNA was
excised with KpnI and NotI and ligated into the
Afl II and NotI sites of NaSi-1, after filling in the
KpnI and Afl II sites with Klenow. For the homolo-
gous recombination procedure, the SiDC tandem con-
struct was linearized between the cDNA inserts using
MunI and Sal I. DH5a cells were transformed with
the linearized construct. Plasmid DNA was purified
from carbenecillin-resistant colonies and the size
checked on agarose gels. Monomer size plasmids
were subjected to restriction digests to determine the
approximate location of the junction between the two
cDNAs. The precise location of the junction was
verified by sequencing. Of the 42 recombinant plas-
mids tested, most contained complete or almost com-
plete overlaps of the coding region. However, one
plasmid contained a chimeric insert, called SiDC-4
 .Fig. 1 , which consisted of the first four transmem-
brane domains of NaSi-1 and the last seven trans-
membrane domains of NaDC-1. Although the reverse
 .tandem construct was made DCSi , it yielded no
circularized plasmids after two separate transforma-
tions.
2.2. Formation of chimeras by PCR
Three additional chimeras were prepared by Over-
w xlap Extension PCR 8 . Chimera DS1 consisted of
amino acids 1–402 of NaSi-1 followed by amino
acids 390–593 of NaDC-1 note that there are gaps
w x.and inserts in the alignment of the two sequences, 2
 .Fig. 1 . Chimera DS2 contained amino acids 141–
389 of NaDC-1 flanked by NaSi-1 at the N- and
 .C-termini Fig. 1 . Chimera DS3 contained amino
 .Fig. 1. Wild-type and chimeric transporters. A Secondary struc-
ture models of the wild-type Naqrsulfate cotransporter, NaSi-1
 . q  .white , and Na rdicarboxylate cotransporter, NaDC-1 grey .
 .B Functional chimera SiDC-4, consisting of the first four
 .transmembrane domains TMD of NaSi-1 and the last seven
 .TMD of NaDC-1. C Non-functional chimeras, DS1, DS2, and
DS3, each containing a junction just past TMD 8.
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acids 1–389 of NaDC-1 followed by amino acids
 .403–595 of NaSi-1 Fig. 1 . The primers used for






Chimera DS3 was made by subcloning a fragment of
NaDC-1 into the DS2 chimera. The ‘‘outside’’
primers used in this procedure were vector specific:
the T7 and SP6 promoter primers. The PCR amplifi-
cation reactions were performed using AmpliTaq
 .polymerase Perkin Elmer–Cetus with the following
parameters: 948C for 3 min, followed by 35 cycles of
1 min at 948C, 1 min at 608C, 3 min at 728C, and a
final extension at 728C for 7 min. The chimeric cD-
NAs were subcloned into pSPORT1, and verified by
sequencing.
2.3. In ˝itro cRNA transcription
The parental and chimeric cDNAs were used as
templates for cRNA synthesis. Plasmids were lin-
earized with NotI and in vitro cRNA transcription
was done using the T7 mMessage mMachine Kit
 .Ambion . The cRNAs were resuspended in water to
a final concentration of 0.5 to 1 mgrml.
2.4. Xenopus oocytes
Stage V and VI oocytes from Xenopus lae˝is
were dissected and collagenase treated as described
w xpreviously 2 . Oocytes were cultured at 188C in
Barth’s medium supplemented with 5% heat-in-
activated horse serum, 2.5 mM sodium pyruvate and
50 mgrl gentamicin. Culture dishes and medium were
changed daily.
2.5. Transport experiments
w14 x  .Transport of C -succinate DuPont-NEN ,
w14 x  . w14 x C -citrate Moravek , C -glutarate American
. w35 x Radiolabelled Chemical , and S -sulfate DuPont-
.NEN was measured five to seven days after oocyte
w xinjections, also as described 2 . Sodium and choline
 .buffers in mM were as follows: 100 mM NaCl or
Choline, 2 mM KCl, 1 mM MgCl , 1 mM CaCl ,2 2
10 mM Hepes–Tris, pH 7.5. The oocytes were rinsed
briefly with choline buffer to remove sodium and
serum. Transport was initiated by replacement of the
choline rinse with 0.4 or 0.75 ml kinetic experi-
.ments of the appropriate transport buffer as de-
scribed in the figure legends. Transport was stopped
after the appropriate time by 4=4 ml washes with
ice-cold choline buffer. Individual oocytes were
transferred to scintillation vials and dissolved in 0.5 ml
10% SDS. Scintillation cocktail was added and ra-
dioactivity was counted. Counts in control uninjected
oocytes were subtracted from the counts in cRNA-in-
jected oocytes. Data are presented as means"SE.
Calculations of kinetic constants were done by non-
linear regression to the Michaelis–Menten equation,
 .using the SigmaPlot program Jandel Scientific . Sta-
tistical analysis was done using the SigmaStat Pro-
 .gram Jandel Scientific .
2.6. Western blots of purified of plasma membranes
Plasma membranes were purified from Xenopus
w xoocytes by the method of Geering and co-workers 9 ,
w xand were blotted onto nitrocellulose as described 4 .
The nitrocellulose membranes were blocked for a
minimum of 1 h in PBS-TM phosphate-buffered
saline containing 0.05% Tween 20 and 0.5% Carna-
.tion instant dried milk . The Western blots were
probed with an antibody directed against a fusion
w xprotein of NaDC-1 4 . The primary antibody was
diluted 1:10 000 in PBS-TM, and applied for 1 h,
after which the secondary antibody, horseradish per-
 .oxidase-linked anti-rabbit Ig Amersham , was di-
luted 1:5000 in PBS-TM and applied for 1 h. All
incubations and washes were done at room tempera-
ture. Antibody binding was visualized by enhanced
chemiluminescence using the Supersignal CL-HRP
 .substrate system Pierce . Molecular weights were
estimated by comparison with pre-stained protein
 .standards BioRad . The Western blots were scanned
with a Microtek Scanmaker E3 scanner, and peak
mass and intensity were calculated using SigmaGel
 .software Jandel Scientific .
2.7. Deglycosylation
 .Plasma membranes 4 mg from Xenopus oocytes
injected with NaDC-1 cRNA were denatured in 0.5%
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SDS, 1% b-mercaptoethanol at 1008C for 10 min.
The deglycosylation reaction was carried out in
50 mM sodium phosphate, pH 7.5, 1% NP-40 and
between 500–750 units Peptidyl N-Glycanase F
 .  .PNGase F New England Biolabs at 378C for 1 h.
Control reactions were run in the absence of PNGase
F.
3. Results
3.1. Chimera formation and characterization
The method of homologous recombination was
used to generate chimeras between NaDC-1 and
 .NaSi-1, which share 43% sequence identity Fig. 1 .
Most of the chimeras produced by this method con-
tained complete or almost complete overlaps of the
coding region. However, one chimera was formed,
SiDC-4, that contained amino acids 1–139 of NaSi-1
followed by amino acids 141–593 of NaDC-1. Note
that the N-terminus of NaSi-1 is shorter than that of
NaDC-1, and amino acids 139–141 in NaSi-1 are
.identical to amino acids 140–142 of NaDC-1.
Chimera SiDC-4 corresponds approximately to the
first four transmembrane domains of NaSi-1 followed
by the last seven transmembrane domains of NaDC-1.
Three additional chimeras, called DS1, DS2 and DS3,
 .were generated using a PCR-based method Fig. 1 .
w xAs shown in previous studies 2,3 , the parental
transporters, NaDC-1 and NaSi-1, carry completely
different substrates. NaDC-1 transports succinate but
  ..does not transport sulfate Fig. 2 A . Furthermore,
the transport of succinate by NaDC-1 is not inhibited
w xby up to 10 mM sulfate 2 . Similarly, NaSi-1 carries
only sulfate, and does not interact with succinate
  ..Fig. 2 A . The chimeric transporter, SiDC-4, retains
the transport characteristics of the parental NaDC-1
  ..since it carries succinate but not sulfate Fig. 2 B .
SiDC-4 also transports citrate and glutarate Fig.
 ..2 B , similar to the substrate specificity of NaDC-1
w x10 . In three separate experiments, we were unable
to measure any succinate, citrate, glutarate or sulfate
transport in oocytes expressing chimeras DS1, DS2
 .or DS3 not shown .
3.2. Substrate specificity of SiDC-4
The substrate specificity of SiDC-4 was further
tested by measuring the transport of succinate in the
 .presence of potential inhibitors Fig. 3 . The substrate
specificity of SiDC-4 appears to be very similar to
that of the parental NaDC-1. The greatest inhibition
of SiDC-4 transport was seen with di- and tricarbox-
ylates including succinate, fumarate, citrate, a-keto-
glutarate, and malate. However, SiDC-4 appears to
w xbe more sensitive to these inhibitors than NaDC-1 2 ,
 .Fig. 2. A Transport of succinate and sulfate in control, uninjected oocytes and oocytes expressing the parental transporters, NaDC-1 and
NaSi-1. The transport of 100 mM succinate or sulfate was measured over a 15 min time period in sodium containing buffer. Values shown
 .are means"SE, ns5 oocytes. B Transport in SiDC-4-injected oocytes. Transport of succinate, citrate, glutarate and sulfate was
compared in control, uninjected oocytes and oocytes expressing SiDC-4. Transport conditions were the same as in A.
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Fig. 3. Substrate specificity of the SiDC-4 chimera. Transport of
10 mM succinate was measured in the presence or absence of
1 mM concentrations of test inhibitors. Sulfate was tested at
1 mM and 10 mM concentrations. Fifteen minute uptakes were
measured in sodium containing buffers. Data shown are means"
SE, ns5 oocytes. ) denotes significant difference from con-
.trol, P -0.05 .
suggesting an increased substrate affinity in the
chimera compared with the parental transporter. There
was no inhibition of succinate transport by up to
10 mM sulfate. Succinate transport by SiDC-4 was
inhibited by flufenamate, although the sensitivity of
SiDC-4 to flufenamate was lower than seen in the
w xwild-type NaDC-1 4 . SiDC-4 was not significantly
inhibited by 1 mM furosemide, which inhibits NaDC-
w x1 by approximately 50% 4 .
3.3. SiDC-4 kinetics
The concentration dependence of succinate trans-
port by SiDC-4 is shown in Fig. 4. Because of the
low expression of SiDC-4 relative to control oocytes,
the kinetic data should be considered as estimates
only. The apparent K for succinate was 59"24 mMm
and the apparent V was 391"23 pmolroocyterh.max
In a second experiment, the kinetics of succinate
transport by SiDC-4 and NaDC-1 were compared in
the same batch of oocytes. The apparent K form
succinate by SiDC-4 was 108"82 mM and the Vmax
 .was 408 " 62 pmolroocyterh n s 5 oocytes .
Oocytes injected with NaDC-1 cRNA had a K form
succinate of 243"49 mM and a V of 11 830"max
 .696 pmolroocyterh ns5 oocytes . In previous
studies, the K for succinate in NaDC-1 was 0.5 mMm
w x2,10 . It should be noted that the K for succinate inm
NaDC-1 varies with oocyte batches, probably due to
w xvariations in membrane potential 11 .
3.4. Cation selecti˝ity in SiDC-4
The SiDC-4 chimera had altered cation specificity
compared with NaDC-1 and NaSi-1. The parental
Naqrdicarboxylate cotransporter, NaDC-1, exhibits
very low transport of succinate when sodium is re-
 .  w x.placed by choline transport of 0.1% Fig. 5 and 2 .
There is slightly higher transport of succinate in
NaDC-1 in 100 mM lithium, approximately 5% of the
transport seen in 100 mM sodium. Similarly, the
Naqrsulfate transporter, NaSi-1, has very low sulfate
transport and low sulfate-dependent currents when
w xsodium is replaced by choline 3,5 . In contrast,
SiDC-4 had a relatively high rate of succinate trans-
port in the presence of choline or lithium, approxi-
 .mately 30% of that seen in sodium Fig. 5 .
The parental NaDC-1 is sensitive to inhibition by
w xmillimolar concentrations of lithium 2,10 , with an
w xapparent K for lithium of around 2 mM 10 . Similari
Fig. 4. Kinetics of succinate transport in control uninjected
oocytes and oocytes expressing the SiDC-4 chimera. Concentra-
tions of succinate ranged from 50 mM to 7 mM, and 10 min
 .uptakes were measured. Data shown are means"SE ns5 . The
K for succinate in SiDC-4 is 59"24 mM and the V ism max
 .391"23pmolroocyterh ns5 , after correction for counts in
uninjected oocytes.
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Fig. 5. Cation specificity of SiDC-4 compared with the parental
transporter, NaDC-1. The transport of 100 mM succinate was
measured in transport buffers containing 100mM sodium, choline
or lithium. Succinate transport was also measured in a combina-
tion of 95mM sodium with 5 mM lithium. Fifteen minute uptakes
 .were measured. Data shown are means"SE ns5 , expressed
as a percentage of control uptakes measured in sodium buffer.
 .Control uptakes were 2856"126pmolroocyterh NaDC-1 and
 .116"13pmolroocyterh SiDC-4 . Uptakes were corrected for
counts in uninjected oocytes.
to our previous results, succinate transport by NaDC-1
was inhibited by 60% in the presence of 5 mM
 .lithium Fig. 5 . NaSi-1 is relatively insensitive to
inhibition by lithium. Transport of 100 mM sulfate by
NaSi-1 decreased only 20% in 5 mM lithium results
.not shown . Unlike either of the parental transporters,
however, the chimera SiDC-4 showed a 1.7-fold
increase in the transport of succinate in the presence
 .of 5 mM lithium Fig. 5 .
3.5. Characterization of anti-NaDC-1 antibodies
The anti-NaDC-1 antibody used in this study was
prepared by injecting the same fusion protein as in
w xour previous study 4 into rabbits rather than chick-
ens. In our previous study, the antifusion protein
antibodies raised in chickens recognized several pro-
teins in the Xenopus oocyte plasma membranes,
which often made it difficult to identify NaDC-1
w xexpressed in oocytes 4 . The rabbit antibodies pre-
pared in this study recognized the same 63 kDa pro-
tein in rabbit renal brush border membrane vesicles
 . w xnot shown as the chicken antibodies 4 .
Plasma membranes prepared from oocytes injected
with NaDC-1 contain a major immunoreactive pro-
tein at 56.7 kDa and a less abundant, broad band of
 .protein centered at 74 kDa Fig. 6 . The 66 kDa pro-
tein recognized by the chicken antibodies in our
w xprevious study 4 appears to correspond to a compo-
nent of the broad 74 kDa band recognized by the
rabbit antibodies. Enzymatic deglycosylation of
NaDC-1 in oocyte membranes using PNGase F re-
sulted in the disappearance of both the 56.7 kDa and
the 74 kDa proteins, and the appearance of an im-
munoreactive signal at 55.5 kDa. Plasma membranes
prepared from oocytes injected with a mutant NaDC-
w x1, called GM2, which lacks N-glycosylation sites 4 ,
had only a single immunoreactive protein at 55.5 kDa.
Therefore, the 55.5 kDa protein probably represents
the unglycosylated form of NaDC-1, and the larger
 .proteins 56.7 and 74 kDa represent heterogeneously
glycosylated forms of the transporter. Interestingly,
the GM2 mutant expresses only ;55% of wild-type
w x .transport 4 and not shown , and it had a ;65%
reduction in the amount of protein at the plasma
membrane relative to oocytes expressing NaDC-1
the lane containing the control NaDC-1 membranes
Fig. 6. Western blot of plasma membranes prepared from Xeno-
pus oocytes. Two mg of protein were loaded into each well of a
10% acrylamide gel. The sample volumes were 10 ml for lane 3
and 30 ml in lanes 1, 2. The blot was probed with a 1:10000
dilution of primary antibody directed against NaDC-1, followed
by a 1:5000 dilution of anti-rabbit IgG. The position of size
 .standards kDa is shown at left. Lane 1: NaDC-1-injected
oocytes, membranes incubated with buffers for deglycosylation
 .reaction same as lane 2 but without enzyme; 2: NaDC-1-
injected oocyte membranes treated with PNGase F; 3: oocytes
 .expressing GM2 mutant NaDC-1 lacking N-glycosylation sites .
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 .  .Fig. 7. A Western blot of plasma membranes prepared from control uninjected oocytes lanes 1,2,3 , and oocytes expressing NaDC-1
 .  . lanes 4,5,6 and SiDC-4 lanes 7,8,9 . Three different protein concentrations were loaded onto the gel for each sample: 5 mg lanes
.  .  .  .1,4,7 , 2.5 mg lanes 2,5,8 and 0.5 mg lanes 3,6,9 . Immunoblot conditions were the same as in Fig. 6. Size standards kDa are indicated
 .  .  .at left. B Western blot of plasma membranes prepared from oocytes expressing NaDC-1 lane 1 and the mutant chimeras DS2 lane 2
 .and DS3 lane 3 . Two mg protein were loaded in each lane. Other conditions were the same as described in Fig. 6.
.  .is not shown Fig. 6 , suggesting that the removal of
glycosylation sites impairs protein trafficking or sta-
bility.
3.6. Western blots of oocyte membranes
Plasma membranes were prepared from control,
uninjected oocytes or oocytes expressing NaDC-1 or
the chimera, SiDC-4. The membrane proteins were
separated by SDS-PAGE in two gels run in parallel.
Each gel contained three different amounts of each
 .protein sample 5, 2.5, and 0.5 mg . One of the gels
was used for Coomassie blue staining, to verify the
amount of protein loaded into each well, and the
second gel was used for Western transfer and blot-
ting. The exposure time of the film was varied to
ensure a linear response. The Coomassie Blue stained
gel showed that sample loading was approximately
 .the same among the three samples not shown . As
 .shown in Fig. 7 A , there was no immunoreactive
signal in Western blots of membranes from unin-
jected oocytes. A strong immunoreactive protein band
at 56.7 kDa and a less intense signal at 74 kDa were
seen in membranes from oocytes injected with
NaDC-1 or SiDC-4. The relative intensities of SiDC-4
 .compared with NaDC-1 were 98% 5mg protein ,
 .  .132% 2.5 mg and 139% 0.5 mg , indicating that the
abundance of the two proteins was very similar. Fig.
 .7 B shows an immunoblot of membranes prepared
from oocytes injected with the DS2 and DS3
chimeras, both of which contain the epitope for the
anti-NaDC-1 antibodies. Equal amounts of protein
were loaded onto each lane and the film exposure
was varied to ensure a linear response. In plasma
membranes from oocytes expressing the DS2 and
DS3 chimeras there were two immunoreactive pro-
teins. One protein had the same apparent mass as the
non-glycosylated form of NaDC-1, 55 kDa. The sec-
ond protein, at 106.7 kDa, could represent aggrega-
tion of the 55 kDa protein. There was no evidence of
the usual proteins seen in NaDC-1-injected oocytes at
56.7 and 74 kDa. The abundance of the 55 kDa pro-
tein in DS3 plasma membranes was very low, only
34% of NaDC-1, whereas the DS2 chimera appeared
 .to be more abundant than NaDC-1 212% .
4. Discussion
The Naqrdicarboxylate and Naqrsulfate cotrans-
porters are members of the same gene family, sharing
43% sequence identity and similar hydropathy pro-
files. The two transporters are therefore likely to have
very similar protein structures. Functionally, NaDC-1
and NaSi-1 are similar in coupling 3 sodium ions to
the transport of a divalent anion substrate. However,
the substrate specificities of these transporters are
distinct from one another. NaDC-1 carries Krebs
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cycle intermediates, such as succinate and citrate,
whereas NaSi-1 carries inorganic sulfate and thiosul-
fate. The chimera SiDC-4 contains the first 4 trans-
 .membrane domains amino acids 1–139 of NaSi-1
and the last 7 transmembrane domains amino acids
.141–593 of NaDC-1, but it retains the substrate
selectivity of the NaDC-1 parent. Therefore, the
residues involved in discriminating between succinate
and sulfate are located distal to amino acid 141.
There is very little information about the structures
of the substrate and ion binding domains in ion-cou-
pled transporters. In sugar transporters, the substrate
binding site appears to be located in the carboxy-
terminal half of the protein. For example, the car-
boxy-terminal half of lac permease has been ex-
pressed in functional form, and it catalyzes downhill
w xlactose transport 12 . The residues that discriminate
between sugar substrates are found in transmembrane
 .segment 10 in the yeast glucose Hxt2 and galactose
 . w xGal2 transporters 13 . Furthermore, the carboxy-
terminal half of the low and high affinity Naqrglu-
cose cotransporters, SGLT1 and SGLT2, contains
w xresidues that determine substrate affinity 14 . How-
ever, the location of the substrate recognition site in
transporters that do not carry sugars is not necessarily
at the carboxy-terminus. For example, the Hq-peptide
cotransporters appear to have their substrate binding
w x qsites located near the amino terminus 15 . The Na -
coupled dopamine and norepinephrine transporters
have domains that determine substrate affinity lo-
cated in both the amino- and carboxy-terminus,
whereas the residues that discriminate between sub-
w xstrates are found near transmembrane domain 2 7 .
The sequences of NaDC-1 and NaSi-1 are not
related to the sequences of other transporters. The
predicted secondary structure of NaDC-1 and proba-
.bly also NaSi-1 is also slightly different than that of
other transporters, having 11 transmembrane domains
and an extracellular, N-glycosylated, carboxy-
w xterminus 4 . However, the location of the substrate
recognition domain in NaDC-1 and NaSi-1 appears to
be in the carboxy-terminal portion of the protein, past
amino acid 141, similar to the sugar transporters. The
SiDC-4 chimera has a substrate selectivity that re-
sembles the substrate selectivity of the parental
NaDC-1. Just like NaDC-1, SiDC-4 transports succi-
nate, citrate and glutarate but does not interact with
sulfate. Succinate transport by SiDC-4 was inhibited
by a range of di- and tricarboxylic acids, similar to
the substrate specificity of NaDC-1.
The SiDC-4 chimera exhibited an increase in sub-
strate affinity compared with NaDC-1. SiDC-4 had
an increased sensitivity to inhibition of succinate
transport by test substrates and a lower apparent Km
for succinate. This result suggests that substrate affin-
ity could be affected by residues in the amino-
terminus of the protein, similar to the neurotrans-
w xmitter transporters 7 . However, another possible
explanation is that the alteration in cation binding
seen in SiDC-4 affects its substrate affinity. The
turnover number for succinate appears to be reduced
in the SiDC-4 chimera because the V was muchmax
lower than the V of NaDC-1 although the abun-max
dance of the two proteins in the plasma membrane
was similar.
Interestingly, the residues involved in binding sub-
strates and those involved in binding the inhibitors,
flufenamate and furosemide, are found in different
portions of the proteins. The parental rabbit NaDC-1
is sensitive to inhibition by flufenamate and
furosemide with IC ’s of 250 mM and 2 mM, respec-50
w xtively 10 . The chimera SiDC-4 was not inhibited by
furosemide and was relatively insensitive to inhibi-
tion by flufenamate, which resembles the properties
of the human isoform, hNaDC-1, more than the
w xparental NaDC-1 10 . It is possible that amino acids
in the amino-terminus that are common between
hNaDC-1 and NaSi-1 could determine the sensitivity
to these inhibitors. Alternately, the interaction be-
tween residues in the amino- and carboxy-terminus of
the protein could determine inhibitor sensitivity.
The two parental transporters, NaDC-1 and NaSi-1,
couple three sodium ions to the transport of each
divalent anion substrate. However, they differ in their
sensitivity to inhibition by lithium, which is thought
to bind to one of the sodium binding sites in NaDC-1
w x16 . This functional difference suggests that the
structure of at least one of the sodium binding sites is
different between NaDC-1 and NaSi-1. Surprisingly,
the SiDC-4 chimera had cation binding properties
that were unlike those of either parental transporter.
SiDC-4 exhibited a relatively low cation selectivity,
with transport seen in the presence of both choline
and lithium. Furthermore, rather than being inhibited
by lithium, the transport of succinate by SiDC-4 was
stimulated by 5 mM lithium. This result suggests that
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the lithium can substitute for sodium with a high
affinity in SiDC-4. Therefore, the cation binding sites
in NaDC-1 and SiDC-4 may be composed of interact-
ing residues from both the amino- and carboxy-termi-
nal portions of the protein.
Further testing of the domains responsible for sub-
strate discrimination in these transporters was not
possible in our study. The formation of chimeras,
although a useful approach in structure-function stud-
ies, may have limitations when the parental proteins
are not very similar in sequence. NaDC-1 and NaSi-1
are only 43% identical in sequence. The homologous
recombination approach, which relies on sequence
similarities, only yielded one viable chimera. The
PCR-based approach, although more directed, did not
produce any functional chimeras with the substrates
tested, succinate, citrate, glutarate and sulfate. It is
likely, based on the Western blots of DS2 and DS3,
that these chimeras were misfolded or improperly
targeted to the plasma membrane. Others have re-
ported similar problems in forming chimeras between
proteins with such different sequences. For example,
attempts to produce chimeras between the nor-
epinephrine and serotonin transporters 47% identi-
.cal yielded no functional chimeras containing switch
w xpoints past the amino-terminal tail 6 .
In conclusion, the SiDC-4 chimera retains the
substrate specificity of the parental Naqrdicarboxy-
late cotransporter, NaDC-1, suggesting that the
residues determining substrate selectivity are found in
the 7 transmembrane domains near the carboxy-
terminus of the protein. However, the SiDC-4 chimera
has an increased substrate affinity, suggesting that
residues in the first four transmembrane domains may
also influence substrate binding. The binding site for
the inhibitors furosemide and flufenamate appears to
reside in the amino terminal portion of the protein.
Finally, although the parental transporters have simi-
lar cation binding properties, the SiDC-4 chimera had
altered cation selectivity, and exhibited a stimulation
of transport in the presence of lithium.
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